Diplomat Pharmacy, Inc. (DPLO) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 226 transactions totaling $315.3M, demonstrating a bearish sentiment with -$314.7M in net insider flow. The most recent transaction on Feb 10, 2020 involved a transaction of 41,019 shares valued at $164.1K.
No significant insider buying has been recorded for DPLO in the recent period.
No significant insider selling has been recorded for DPLO in the recent period.
Based on recent SEC filings, insider sentiment for DPLO is bearish with an Insider Alignment Score of 0/100 and a net flow of -$314.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Diplomat Pharmacy, Inc. (DPLO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading DPLO stock, having executed 226 transactions in the past 90 days. The most active insider is Philip R. Hagerman (Executive), who has made 66 transactions totaling $248.9M.
Get notified when executives and directors at DPLO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 10, 2020 | M. Benjamin Regina | Executive | Disposition | 41,019 | $4.00 | $164.1K | |
| Feb 10, 2020 | Paul Davison Daniel | Executive | Disposition | 43,209 | $N/A | $0 | |
| Feb 10, 2020 | Paul Davison Daniel | Executive | Disposition | 200,000 | $N/A | $0 | |
| Feb 10, 2020 | C. Dreyer David | Executive | Disposition | 20,674 | $4.00 | $82.7K | |
| Feb 10, 2020 | C. Dreyer David | Executive | Tender | 19,453 | $4.00 | $77.8K | |
| Feb 10, 2020 | T. Griffin Brian | Executive | Disposition | 204,457 | $4.00 | $817.8K | Large |
| Feb 10, 2020 | T. Griffin Brian | Executive | Tender | 11,238 | $4.00 | $45.0K | |
| Feb 10, 2020 | T. Griffin Brian | Executive | Tender | 124,875 | $4.00 | $499.5K | |
| Feb 10, 2020 | T. Griffin Brian | Executive | Disposition | 583,580 | $4.00 | $2.3M | Large |
| Feb 10, 2020 | T. Griffin Brian | Executive | Disposition | 22,478 | $N/A | $0 | |
| Feb 10, 2020 | T. Griffin Brian | Executive | Disposition | 408,915 | $N/A | $0 | |
| Feb 10, 2020 | T. Griffin Brian | Executive | Disposition | 84,375 | $N/A | $0 | |
| Feb 10, 2020 | R. Hagerman Philip | Executive | Tender | 1,075,293 | $4.00 | $4.3M | Large |
| Feb 10, 2020 | R. Hagerman Philip | Executive | Tender | 1,475,876 | $4.00 | $5.9M | Large |
| Feb 10, 2020 | R. Hagerman Philip | Executive | Tender | 1,475,876 | $4.00 | $5.9M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 89 | $315.0M | 80.3% |
Tender(U) | 27 | $70.5M | 18.0% |
Disposition(D) | 16 | $3.9M | 1.0% |
Exercise(M) | 18 | $2.5M | 0.6% |
Purchase(P) | 6 | $336.8K | 0.1% |
Award(A) | 56 | $0 | 0.0% |
Gift(G) | 6 | $0 | 0.0% |
Other(J) | 8 | $0 | 0.0% |
Insider selling pressure at Diplomat Pharmacy, Inc. has increased, with 20 insiders executing 226 transactions across all time. Total sales of $315.0M significantly outpace purchases of $336.8K, resulting in a net outflow of $314.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.